Search

Begin New Search Topic Drugs Publication Year within 5 Years

21. No Boundaries – The Syrian-Lebanese Drug Economy

Author:
Moran Levanoni
Publication Date:
12-2021
Content Type:
Working Paper
Institution:
Moshe Dayan Center for Middle Eastern and African Studies
Abstract:
In this issue of Iqtisadi, Dr. Moran Levanoni analyzes how the Syrian-Lebanese border area has become one of the most important centers for the production of illegal drugs in the Middle East. Hezbollah's key role in the Middle East drug trade is contextualized within its global empire that includes parts of South America, Africa, and Eurasia.
Topic:
Economy, Hezbollah, Drugs, and Illicit Financial Flows
Political Geography:
Middle East, Lebanon, and Syria

22. Enforcement of Drug Laws: Refocusing on Organized Crime Elite

Author:
Global Commission On Drug Policy
Publication Date:
05-2020
Content Type:
Special Report
Institution:
Global Commission On Drug Policy
Abstract:
In this first report of this decade, the Global Commission on Drug Policy outlines how the current international drug control regime works for the benefit of transnational organized crime. It highlights how years of repressive policies targeted at nonviolent drug offenders have resulted in mass incarceration and produced countless adverse impacts on public health, the rule of law, and social cohesion, whilst at the same time reinforcing criminal elites. The report argues that the top layers of criminal organizations must be disempowered, through policy responses and political will. It provides implementable recommendations for the replacement of the current policy of targeting non-violent drug offenders and resorting to mass incarceration. Law enforcement must focus on the most dangerous and protected actors and primary drivers of the corruption, violence, and chaos around illegal drug markets. The control of psychoactive substances in a rational and efficient way must be centered on people and their needs, and on a repressive approach against criminal elites who benefit from the illegal drug markets’ proceeds, and have access to high-level networks, financial and legal support as needed. Only responsible legal regulation of currently prohibited drugs, with careful implementation, has the potential to disrupt criminal organizations and deprive them of their most lucrative sources of income. The report contains research on the prerequisites for a successful transition towards the reform of the outdated ideology-based international drug control regime, and provides cutting-edge recommendations on how to ensure that international criminal organizations are effectively disempowered by the transition towards a legally regulated drug market under the control of governments.
Topic:
Crime, Health, War on Drugs, Drugs, Public Health, and Medicine
Political Geography:
Global Focus

23. Illicit Drug Trafficking and Use in Libya: Highs and Lows

Author:
Fiona Mangan
Publication Date:
05-2020
Content Type:
Special Report
Institution:
United States Institute of Peace
Abstract:
This report explores how illicit drug trafficking and drug use in Libya has shaped and been shaped by the country’s ongoing conflict. Drawing on hundreds of interviews and dedicated research, it examines Libya’s pre-2011 illicit economy, delves into the social impact of drugs, and focuses on drug use on the frontlines of Libya’s ongoing conflict, the corrosive impact of drug trafficking and use on the justice and security sector, and how trafficking and organized crime undercut peacebuilding and state consolidation.
Topic:
Trafficking, Conflict, Peace, and Drugs
Political Geography:
Libya and North Africa

24. Solutions for the “Vanishing Drug” Conundrum in Lebanon: A Change in the Subsidy System Coupled with a Digital Prescribing Platform

Author:
Nadim El Jamal, Ulfat Usta, Mona Nasrallah, Elie Al-Chaer, Ghassan Hamadeh, and Hussain Isma'eel
Publication Date:
11-2020
Content Type:
Working Paper
Institution:
Arab Reform Initiative (ARI)
Abstract:
The shortage of foreign currency caused by the multiple crises in Lebanon threatens the availability of pharmaceutical products, with patients experiencing shortages of many drugs despite an importation subsidy system for pharmaceuticals financed by the Central Bank’s foreign reserves. This paper describes Lebanon’s pharmaceutical supply chain and the Central Bank’s subsidy system and proposes recommendations to ensure the continuous availability of medication on pharmacy shelves.
Topic:
Health, Drugs, Medicine, and Pharmaceuticals
Political Geography:
Middle East and Lebanon

25. La captura del Estado peruano por el narcotráfico: el caso de los “cuello blanco del puerto” (The Capture of the Peruvian State by Drug Trafficking: the Case of «the White Collars of the Port»)

Author:
Laura Zúñiga Rodríguez
Publication Date:
12-2020
Content Type:
Journal Article
Journal:
Journal on International Security Studies (RESI)
Institution:
International Security Studies Group (GESI) at the University of Granada
Abstract:
Desde los años ochenta el Perú es una pieza clave en el escenario internacional del tráfico de drogas. Segundo productor de cocaína del mundo y uno de los países donde se cultiva el principal insumo, la hoja de coca, el puerto de El Callao, siendo uno de los principales puertos de América Latina por su volumen, se presume que es desde donde salen importantes cargas de esa droga. La interceptación de las comunicaciones en 2018 para investigar el crimen organizado violento que se desarrollaba en esa Provincia, desveló una red de jueces, fiscales, congresistas, empresarios, que colaboraban con los narcotraficantes favoreciéndoles con la impunidad. No es el primer intento de captura del Estado peruano por el narcotráfico. En la década de los noventa, el gobierno de Fujimori-Montesinos, utilizó el dinero del narcotráfico –entre otros- para sobornar a las más altas autoridades del país: jefes militares, Corte Suprema, Fiscal de la Nación, medios de comunicación, empresarios, todos afines al gobierno. Los “narcoindultos” del segundo gobierno de Alan García son otro síntoma de la gravedad de la colaboración de autoridades de las más altas esferas del Estado con los poderosos narcotraficantes. Se pone en evidencia la “doble moral” de la Política Criminal peruana contra el tráfico internacional de drogas, fuerte para los débiles y débil para los fuertes: penas altas para los pequeños traficantes e impunidad para los que se encuentran en el vértice de las organizaciones criminales. Además, resulta preocupante la enorme capacidad corruptora del dinero proveniente del narcotráfico (blanqueo de dinero) para capturar miembros de los poderes del Estado: Ejecutivo, Legislativo y Judicial. El caso “cuellos blanco del puerto” es una muestra empírica de la intersección de la corrupción judicial –y sus adláteres- dentro del Estado peruano y las organizaciones del crimen organizado. Para conjurar estas alianzas, es preciso poner el acento en la punición de los delincuentes de cuello blanco del narcotráfico y sus colaboradores: abogados, jueces, fiscales, etc., que utilizan su profesión como tapadera para enriquecerse personalmente, en desmedro del bien común.
Topic:
Corruption, Trafficking, Financial Crimes, Impunity, Drugs, Judiciary, and White Collar Crime
Political Geography:
South America and Peru

26. Cartel Presence by State; Jalisco Nueva Generacion Cartel(CJNG) Achieves the Top Spot in the Country-Wide Territorial Campaign, Surpassing Sinaloa Cartel’s Control Throughout Mexico

Author:
Machiko Olivera
Publication Date:
09-2020
Content Type:
Special Report
Institution:
TRAC: Terrorism Research & Analysis Consortium
Abstract:
Despite the fact that the federal government has ordered the deployment of the armed forces in the country to combat drug traffickers, at least nineteen (19) cartels have active operations throughout the country, of which four (4) have a presence in more than ten (10) state – Jalisco Nueva Generación Cartel (CJNG) being the largest.
Topic:
War on Drugs, Violent Extremism, Trafficking, Drugs, and Legal Sector
Political Geography:
United States and Mexico

27. FARC–Hezbollah: The success of Venezuela–Iran proxy groups and their convergence in the Americas

Author:
Jeferson Guarin P.
Publication Date:
12-2020
Content Type:
Journal Article
Journal:
Security and Defence Quarterly
Institution:
War Studies University
Abstract:
Persistence and adaptation are the main characteristics that have allowed FARC and Hezbollah to become perhaps the most successful proxy groups in recent years. Both Iran and Venezuela have sponsored the military, political and criminal actions of these alleged insurgent organisations. The main objective of this research was to identify and conceptualise the mitotic evolution of FARC and Hezbollah from purely armed organisms into consolidated political organisations in Colombia and Lebanon, and how this evolution has presented a criminal convergence in Venezuela based on drug trafficking and money laundering. This article is based on a comparative case-study of published research papers, documents, and official statements of FARC and Hezbollah, by applying a rational perspective that allows their performance to be deduced. The research results showed a constant mutation of these hybrid threats. Thus, not only was the political and military success of these organisations established but also the strategic support of a criminal dimension which converged in Venezuela, where the FARC drug trafficking and Hezbollah money laundering were amalgamated. Consequently, the investigation exposes the possible consequences of the FARC-Hezbollah criminal convergence in the Americas and its destabilising effects in the next decade.
Topic:
Narcotics Trafficking, Hezbollah, Drugs, FARC, Destabilization, Money Laundering, and Proxy Groups
Political Geography:
Iran, South America, and Venezuela

28. Blueprint for a Market-Driven Value-Based Advance Commitment for Tuberculosis

Author:
Kalipso Chalkidou, Martina Garau, Rachel Silverman, and Adrian Towse
Publication Date:
02-2020
Content Type:
Special Report
Institution:
Center for Global Development (CGD)
Abstract:
Innovation—delivering new drugs, diagnostics, and devices—is a critical tool in the global fight against disease and premature death. Yet despite the potential for innovation to improve health around the world, the pharmaceutical industry’s investments in research and development (R&D) generally neglect diseases of the poor in favour of more lucrative high-income markets. Responding to this R&D gap, donor “push” investments have helped advance an innovation agenda to serve low- and middle-income countries. Though these investments have helped accelerate market entry of several important innovations, other donor-push products have fizzled upon market entry due to unaffordable or non-cost-effective pricing, disappointing efficacy, lack of political will, or lower-than-anticipated country demand. And with many large middle-income countries (MICs) poised to soon transition from donor aid, the sustainability of the current donor-led model is in question. Tuberculosis (TB), an infectious disease primarily affecting the poor and vulnerable, ranks among the top 10 global causes of death. Current TB treatment cycles are long and toxic, causing some patients to discontinue treatment, develop acquired drug resistance, and risk spreading a drug-resistant pathogen to others. Drug-resistant strains are more difficult to treat, traditionally requiring long-duration toxic regimens and high-cost hospitalization (though recent innovations offer a shorter, more tolerable, and more affordable treatment). Despite years of global investment in TB control, modelling suggests that global goals for TB cannot be achieved without major technological breakthroughs. One particularly desirable innovation would be a short-course universal drug regimen (UDR)—equally capable of treating drug-sensitive and drug-resistant strains, with a two-month or shorter treatment duration. Donors, particularly the Bill & Melinda Gates Foundation (BMGF), have funded substantial early-stage R&D to source new treatment compounds that could contribute to a UDR, but substantial additional investments in late-stage trials would be required to bring such a UDR to market.
Topic:
Health Care Policy, Drugs, Medicine, and Pharmaceuticals
Political Geography:
Global Focus